Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 2Head and Neck Neoplasms 2Carcinoma 2Sexual Dysfunction, Physiological 1Pyridoxine-dependent epilepsy 1Prostatic Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mouth Neoplasms 1Liver Neoplasms 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Cisplatin 7Cetuximab 6Radiotherapy, Intensity-Modulated 4pembrolizumab 3durvalumab 3Radiotherapy 2Radiation 2Observation 2Drug Therapy 2Celecoxib 2Bupropion 2130-nm albumin-bound paclitaxel 2trametinib 1sodium thiosulfate 1gluconic acid 1ficlatuzumab 1Zinc 1Watchful Waiting 1Varenicline 1Transcutaneous Electric Nerve Stimulation 1Tobacco Use Cessation Devices 1Tadalafil 1Sirolimus 1RRx-001 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Pilocarpine 1Photochemotherapy 1Periodontal Debridement 1Oral Hygiene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Mouth Neoplasms × Tadalafil × Clear all
NCT03993353 2026-02-12

Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer

University of California, San Diego

Phase 2 Completed
7 enrolled 14 charts
GastrointestinalHead & Neck

Pyridoxine-dependent epilepsy, Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Esophageal Neoplasms, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡